,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,7.9171731849171e-18,6.52375070437169e-15
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,1.65768797656745e-09,6.82967446345791e-07
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,2.64114317918472e-09,7.25433993216069e-07
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,5.52110650572296e-09,1.13734794017893e-06
5,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,4.65896577721945e-07,7.67797560085766e-05
6,WP_COMPLEMENT_ACTIVATION,12,Up,9.26456644894676e-07,0.000127233379232202
7,WP_MEVALONATE_PATHWAY,7,Down,2.73695083857521e-06,0.000322178212997996
8,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,6.65137652428989e-06,0.000685091782001859
9,WP_PROSTAGLANDIN_SIGNALING,25,Down,8.67957768031806e-05,0.0079466355650912
10,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,9.7390993790777e-05,0.00802501788836002
11,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000107588773694313,0.0080593772294649
12,WP_SPINAL_CORD_INJURY,69,Down,0.000121185945435412,0.0083214349198983
13,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.000154128497143275,0.00976937551123528
14,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,0.000173741176102556,0.0102259092220361
15,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.000233759598889129,0.0128411939656428
16,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.000286707054605642,0.0146131879350548
17,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.000304907713688509,0.0146131879350548
18,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.000319220124794887,0.0146131879350548
19,WP_GASTRIN_SIGNALING,92,Down,0.000353679509099408,0.0153385218683112
20,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.000410130008246623,0.0168973563397609
21,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.000472783414024419,0.018551120626482
22,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.000541579769316322,0.0202846240871204
23,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.000706893863551269,0.0253252410246194
24,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.000755623007546294,0.0259430565924228
25,WP_PDGF_PATHWAY,36,Down,0.000795070855507657,0.0262055353975324
26,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.000941110340618542,0.0298259584872953
27,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.000987851471421032,0.0301477634241085
28,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00103428451415677,0.0303802236323533
29,WP_INTEGRINMEDIATED_CELL_ADHESION,73,Down,0.00106920689968234,0.0303802236323533
30,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.00119604024110527,0.0325204714263209
31,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.00122346433764071,0.0325204714263209
32,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00153914435055782,0.0396329670268638
33,WP_G13_SIGNALING,29,Down,0.00182143560758411,0.0454806951711911
34,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.00203341531056451,0.0492804181148575
35,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.00213023509600182,0.0501518205458714
36,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.00253362880456036,0.0565605290317351
37,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.00253973249292985,0.0565605290317351
38,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.00268527228433212,0.058223910968333
39,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.00275574335893809,0.058223910968333
40,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Down,0.00296696266963496,0.0611194309944802
41,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.00319517968488646,0.0628013344090127
42,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,32,Down,0.00320714048933738,0.0628013344090127
43,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.00327725410144119,0.0628013344090127
44,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.00376710684132568,0.0685851819639942
45,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.00389209137298239,0.0685851819639942
46,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00399375755455279,0.0685851819639942
47,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.00406539197356917,0.0685851819639942
48,WP_MAPK_SIGNALING,164,Down,0.00409286200820686,0.0685851819639942
49,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,31,Down,0.00414821023715153,0.0685851819639942
50,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.00416172220655305,0.0685851819639942
51,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.00451882463540254,0.0730100294033665
52,WP_IL1_SIGNALING,53,Down,0.00470849661764239,0.0746115617872564
53,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.00496528791116871,0.0746401253194941
54,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00497893755472733,0.0746401253194941
55,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,92,Down,0.00498204719972351,0.0746401253194941
56,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.00550191398250411,0.0798588113344172
57,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.00552421389085168,0.0798588113344172
58,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.00590687001044241,0.0819651698322598
59,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0059440011462894,0.0819651698322598
60,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.00596833760914513,0.0819651698322598
61,WP_NEUROINFLAMMATION,10,Down,0.00611873187406286,0.0826530338398
62,WP_PROTEASOME_DEGRADATION,57,Down,0.00634906157894419,0.0843810764685486
63,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.00649900247425313,0.0850028260124537
64,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.00677762606997591,0.0872619356509398
65,WP_FOCAL_ADHESION,121,Down,0.00727626237570587,0.0885052816961293
66,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.00728876703778573,0.0885052816961293
67,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.00731098616375204,0.0885052816961293
68,WP_AXON_GUIDANCE,37,Down,0.00739486062699613,0.0885052816961293
69,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.00741124324882636,0.0885052816961293
70,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.00791707096491821,0.0931952353584658
71,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.00809403547310699,0.0939364116878895
72,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.00866864646035098,0.0966238482217831
73,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.00873181960684439,0.0966238482217831
74,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.00879861050387013,0.0966238482217831
75,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0093746057708625,0.0966238482217831
76,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.00937772561532029,0.0966238482217831
77,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.00939103135757354,0.0966238482217831
78,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.00944398110755814,0.0966238482217831
79,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.00957067937849446,0.0966238482217831
80,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.00957067937849446,0.0966238482217831
81,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.00959690837873741,0.0966238482217831
82,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.00961548004148812,0.0966238482217831
83,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,80,Down,0.00976098145418242,0.0969042014246544
84,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.00987953875067487,0.0969135706018582
85,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.0102073980982394,0.0989517180346974
86,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.0104351083674648,0.099982898776639
87,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.0108458044193754,0.102139651037698
88,WP_HEART_DEVELOPMENT,17,Down,0.010981563626862,0.102139651037698
89,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.0110320739591688,0.102139651037698
90,WP_TAMOXIFEN_METABOLISM,2,Up,0.0115291767190913,0.105556017961458
91,WP_CHEMOKINE_SIGNALING,113,Down,0.0119073133162347,0.10782006783052
92,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0124617469411328,0.111613907385799
93,WP_SYNAPTIC_VESICLE_PATHWAY,23,Down,0.0126592653305396,0.112163813251233
94,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,26,Down,0.01361833873494,0.119377777846708
95,WP_MAPK_CASCADE,30,Down,0.0138514924444952,0.120143471308042
96,WP_HYPERTROPHY_MODEL,13,Down,0.0145918269446248,0.12479085302199
97,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0148430372494993,0.12479085302199
98,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.0149328157995688,0.12479085302199
99,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.0149930757878362,0.12479085302199
100,WP_NOTCH_SIGNALING_WP268,35,Down,0.0152373280664818,0.12555558326781
101,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.0158266068036787,0.127944707928701
102,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.0158408722968346,0.127944707928701
103,WP_EGFEGFR_SIGNALING,141,Down,0.0160550598892915,0.127944707928701
104,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.0163300972665677,0.127944707928701
105,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.0163300972665677,0.127944707928701
106,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.0164589066024785,0.127944707928701
107,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.0171531641574869,0.132095395007188
108,WP_ALZHEIMERS_DISEASE,185,Down,0.0177448735950874,0.134144732498643
109,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Down,0.0177448735950874,0.134144732498643
110,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.0179111602074375,0.134170872826623
111,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.0185507698405214,0.137710219356663
112,WP_WNT_SIGNALING_WP363,39,Down,0.0191122544850339,0.140554594746077
113,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0192750839882362,0.140554594746077
114,WP_SPHINGOLIPID_PATHWAY,21,Down,0.0196310515901195,0.141894618511039
115,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0208864327150952,0.149655830932508
116,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.0215912396660901,0.153372254179813
117,WP_NOTCH_SIGNALING_WP61,49,Down,0.0221524246435555,0.156013657318715
118,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0224525468582188,0.156448469223996
119,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.0225938930068634,0.156448469223996
120,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0236036219767125,0.159746278460713
121,WP_INSULIN_SIGNALING,131,Down,0.0236516188104686,0.159746278460713
122,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.0236517548206395,0.159746278460713
123,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.0238972044490557,0.16009184118717
124,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0247060332212754,0.163622433847333
125,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.0250135440483916,0.163622433847333
126,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.0250199352727717,0.163622433847333
127,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.02550438215538,0.165123642366413
128,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0256502745423554,0.165123642366413
129,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0267245258732045,0.170705498600934
130,WP_CHOLESTEROL_METABOLISM,53,Down,0.02724825002635,0.172711984782403
131,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.0280373191997007,0.176356878019491
132,WP_ZINC_HOMEOSTASIS,24,Up,0.02918792840313,0.182203431849842
133,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.030272523860337,0.186538304102823
134,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0309428961642758,0.186538304102823
135,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0312653559027483,0.186538304102823
136,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.0312924025445993,0.186538304102823
137,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.0314635238969981,0.186538304102823
138,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0314882401360941,0.186538304102823
139,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.0315115070613483,0.186538304102823
140,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.0317286598001645,0.186538304102823
141,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,24,Down,0.0319197826195364,0.186538304102823
142,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0321706280321494,0.186680264073881
143,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0325616716628822,0.186715508841342
144,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.0326298947489724,0.186715508841342
145,WP_PEPTIDE_GPCRS,16,Down,0.0346032675232467,0.196506970919671
146,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0348179827114952,0.196506970919671
147,WP_IL26_SIGNALING,33,Down,0.0362615977110518,0.202510969840441
148,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0364323695872966,0.202510969840441
149,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.0366190952745457,0.202510969840441
150,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0370809808340114,0.202680669302988
151,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0371417245931447,0.202680669302988
152,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.0382499653209355,0.207355075160861
153,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.0385416539076056,0.207570737384752
154,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.0391142690806911,0.20759869459195
155,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.0392265048741867,0.20759869459195
156,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0394579923415804,0.20759869459195
157,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.03955460564434,0.20759869459195
158,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0400654398908439,0.208948876392756
159,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0404665959422594,0.209713679600137
160,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.040780436770117,0.210019249366102
161,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.0410767195889498,0.210231161126054
162,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.0415311582885906,0.211244903887646
163,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0418864969293659,0.211745236011028
164,WP_BENZOAPYRENE_METABOLISM,5,Up,0.043846254522702,0.219645539997136
165,WP_COMPLEMENT_SYSTEM,53,Up,0.0439824200236983,0.219645539997136
166,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.045301525296481,0.224870221953616
167,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,78,Down,0.0461295370736581,0.227609212866433
168,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.0481302722616145,0.236067525854586
169,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.0485736632576372,0.236603223159074
170,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.0498035295362065,0.236603223159074
171,WP_TNFALPHA_SIGNALING,84,Down,0.0499271208290222,0.236603223159074
172,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0500530955152559,0.236603223159074
173,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,83,Down,0.0502310462665726,0.236603223159074
174,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.0502952394021056,0.236603223159074
175,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0503587350429149,0.236603223159074
176,WP_NAD_METABOLISM,12,Down,0.050536610771841,0.236603223159074
177,WP_CREATINE_PATHWAY,2,Down,0.0522576065714018,0.242834702728829
178,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.0525394027492534,0.242834702728829
179,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.0527517133355102,0.242834702728829
180,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0536508903786995,0.245601853733602
181,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0545249056916506,0.248223880054807
182,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0550479324099793,0.248805738237933
183,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.0552566141960459,0.248805738237933
184,WP_PURINERGIC_SIGNALING,16,Down,0.0561443560336199,0.250909057031756
185,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.0564125557572767,0.250909057031756
186,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.0566372386018285,0.250909057031756
187,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,9,Up,0.057254185554436,0.252285822977836
188,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0580107397325067,0.254259837976519
189,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.0584010771614757,0.254616336407703
190,WP_WNT_SIGNALING_WP428,60,Down,0.0587443574331149,0.254765002762562
191,WP_SMALL_LIGAND_GPCRS,7,Down,0.0591290152058141,0.255090620573774
192,WP_VITAMIN_D_METABOLISM,6,Down,0.0615836996120303,0.26216293748391
193,WP_HISTONE_MODIFICATIONS,37,Up,0.0617159470110106,0.26216293748391
194,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.0617228275144157,0.26216293748391
195,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.0621301366333775,0.262179356087419
196,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.062363050719823,0.262179356087419
197,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.0634048098060057,0.265205904975374
198,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0657022598907894,0.271221722680461
199,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.0658832898588758,0.271221722680461
200,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0661334273035831,0.271221722680461
201,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0661596677897727,0.271221722680461
202,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.067885409139348,0.276832917610234
203,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.0682003425665989,0.276832917610234
204,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0686040523595007,0.277106564432493
205,WP_TCELL_RECEPTOR_SIGNALING,74,Down,0.0691900234948501,0.278110143218324
206,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.0703306821766328,0.281322728706531
207,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.0717839978533325,0.285309987861275
208,WP_OVARIAN_INFERTILITY,21,Down,0.0720199969358557,0.285309987861275
209,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.072571023471155,0.286117336556132
210,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.0742279002156121,0.289265828034361
211,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0745409762745328,0.289265828034361
212,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.0745998186498704,0.289265828034361
213,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.0747738123438337,0.289265828034361
214,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.0760256973156484,0.291885910268908
215,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.0763984513608391,0.291885910268908
216,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0765654590088356,0.291885910268908
217,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0768680127771275,0.291885910268908
218,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.0795346760577799,0.299446061965412
219,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.0795857858864383,0.299446061965412
220,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.080046009297997,0.29980868937068
221,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.0808097714342681,0.30129978127528
222,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0812025157907827,0.301400328881103
223,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.0820353429981359,0.303126110450511
224,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.0825194167678697,0.303314015555092
225,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.0828223950241453,0.303314015555092
226,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.0833375072916859,0.303850026585616
227,WP_PLEURAL_MESOTHELIOMA,259,Down,0.0844520696750374,0.306510301063838
228,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0848111027215474,0.306510301063838
229,WP_MATRIX_METALLOPROTEINASES,9,Up,0.0856325967561641,0.307360864011108
230,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0861934698034153,0.307360864011108
231,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.0864225229645798,0.307360864011108
232,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0865384956924477,0.307360864011108
233,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.0869379395640739,0.307454344209429
234,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0873972691109105,0.307757904903377
235,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.088894191370801,0.311697079529958
236,WP_PROLACTIN_SIGNALING,69,Down,0.0893190251122918,0.311859647002239
237,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.0900499830154644,0.311997602610718
238,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.090115812404552,0.311997602610718
239,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.092171758662641,0.316682697865913
240,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.0922376789900718,0.316682697865913
241,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0936932422185582,0.32028689503484
242,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0940648405320767,0.32028689503484
243,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.095149526352628,0.320824333379893
244,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,47,Down,0.095154736909344,0.320824333379893
245,WP_P38_MAPK_SIGNALING,31,Down,0.0956279916910797,0.320824333379893
246,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.0959630896973539,0.320824333379893
247,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0961694300301378,0.320824333379893
248,WP_OSTEOBLAST_SIGNALING,3,Down,0.0970058027183763,0.321495603982882
249,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.0975030640637258,0.321495603982882
250,WP_ENDOMETRIAL_CANCER,49,Down,0.0975411419850976,0.321495603982882
251,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0983197084539523,0.322770676358792
252,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0998175235778634,0.32583482774236
253,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.100140884627058,0.32583482774236
254,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.100439376512815,0.32583482774236
255,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.101796662362458,0.327690588202737
256,WP_HEPATITIS_B_INFECTION,119,Down,0.101990785308643,0.327690588202737
257,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.102204467437019,0.327690588202737
258,WP_ERBB_SIGNALING,68,Down,0.104151948281256,0.332640330944785
259,WP_LEPTIN_SIGNALING,69,Down,0.105214858408788,0.334533580566889
260,WP_TAR_SYNDROME,45,Down,0.105761355780019,0.334533580566889
261,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.106048070089416,0.334533580566889
262,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.106480757846152,0.334533580566889
263,WP_ATR_SIGNALING,10,Up,0.106774674379966,0.334533580566889
264,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.107984986594815,0.337044049068665
265,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.108603269773163,0.337694695445608
266,WP_PRION_DISEASE_PATHWAY,28,Down,0.109688149302511,0.339785845959658
267,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.111746696657762,0.344776866690424
268,WP_AGERAGE_PATHWAY,55,Down,0.112136165379895,0.344776866690424
269,WP_THERMOGENESIS,74,Down,0.11328990860075,0.346124277365901
270,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.113508103507835,0.346124277365901
271,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.114076863131143,0.346124277365901
272,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.114254615829521,0.346124277365901
273,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.114979512452695,0.346486124536936
274,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.115712237739066,0.346486124536936
275,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,15,Down,0.115996133223105,0.346486124536936
276,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.116233787328575,0.346486124536936
277,WP_ENDOTHELIN_PATHWAYS,12,Down,0.116476524874674,0.346486124536936
278,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.117668590224661,0.348773087572376
279,WP_BENZENE_METABOLISM,3,Up,0.118138284151525,0.348910201221707
280,WP_COPPER_HOMEOSTASIS,41,Up,0.119813474382604,0.352593938897379
281,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Down,0.120875095967893,0.353843435264432
282,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.121096903816226,0.353843435264432
283,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.122887790501204,0.357595362268605
284,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.123322638373389,0.357595362268605
285,WP_RETT_SYNDROME,32,Down,0.1236828619497,0.357595362268605
286,WP_ENERGY_METABOLISM,41,Down,0.124555132868786,0.358230101550963
287,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.124771892166416,0.358230101550963
288,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.125912491817471,0.360249629366653
289,WP_IRINOTECAN_PATHWAY,5,Up,0.128083708192525,0.365193687026438
290,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.130271167102547,0.37014979893965
291,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.131283184107799,0.37174344915748
292,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.134833475222123,0.380488984873388
293,WP_DRAVET_SYNDROME,14,Down,0.136382254250741,0.383545998302426
294,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.137726219081303,0.384267208650807
295,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.138028024965715,0.384267208650807
296,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.138037735146407,0.384267208650807
297,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.138742052419014,0.384927445095177
298,WP_CORI_CYCLE,11,Down,0.141923831187482,0.391801517163029
299,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Down,0.142170696155031,0.391801517163029
300,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.146232376165635,0.399590963350082
301,WP_NPHP1_DELETION_SYNDROME,10,Down,0.146233108595647,0.399590963350082
302,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.146452027829763,0.399590963350082
303,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.147078067103689,0.399974677536104
304,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,48,Down,0.148772575489487,0.400595512644997
305,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.148794055985853,0.400595512644997
306,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.14912529819125,0.400595512644997
307,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.149250998036425,0.400595512644997
308,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,53,Down,0.15027417549844,0.400958223637096
309,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.151036622735262,0.400958223637096
310,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.151132061619132,0.400958223637096
311,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.151332533435846,0.400958223637096
312,WP_KREBS_CYCLE_DISORDERS,11,Down,0.15274262996727,0.403397202221251
313,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.154896150059536,0.407777724118396
314,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.156346508227531,0.410285104393265
315,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.157870625411805,0.412969509013739
316,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.160129696044144,0.417553384621438
317,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Down,0.162347809552907,0.422001877197463
318,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.165377200132455,0.428524568896676
319,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.169270154723937,0.437237014083149
320,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.170515065073664,0.439076292564684
321,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.172515102790674,0.441409242217762
322,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.17337217549715,0.441409242217762
323,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.173521903691352,0.441409242217762
324,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.17362077518166,0.441409242217762
325,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,54,Down,0.174099519078608,0.441409242217762
326,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.175169990589131,0.442760957808111
327,WP_GPCRS_OTHER,15,Down,0.176889622202542,0.445740210076129
328,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Down,0.177683695086875,0.446376112047516
329,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.179252905974089,0.448949527424466
330,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.180584233074204,0.450747225740166
331,WP_PURINE_METABOLISM,10,Down,0.181069430394202,0.450747225740166
332,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.181887403848379,0.450747225740166
333,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.182158769625577,0.450747225740166
334,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.184185512363822,0.453386985023071
335,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.184326019396515,0.453386985023071
336,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.185532931288906,0.454997426732318
337,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.186936310702852,0.457078694418844
338,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.189086294188818,0.460318532851433
339,WP_NUCLEAR_RECEPTORS,20,Down,0.189378619704655,0.460318532851433
340,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.191493650042759,0.462353176744129
341,WP_G_PROTEIN_SIGNALING,62,Down,0.191892426603541,0.462353176744129
342,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.191899012677782,0.462353176744129
343,WP_MONOAMINE_GPCRS,4,Down,0.19326672488066,0.462955787878019
344,WP_NETRINUNC5B_SIGNALING,35,Down,0.193272804648105,0.462955787878019
345,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,63,Down,0.194261630864236,0.463713678527185
346,WP_SEROTONIN_AND_ANXIETY,7,Down,0.19471472423593,0.463713678527185
347,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.196895698718445,0.467556356610947
348,WP_HUNGER_AND_SATIETY,2,Up,0.199348946570301,0.470774649256999
349,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.199393631784821,0.470774649256999
350,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.201561526016043,0.474465955840505
351,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.202108677791283,0.474465955840505
352,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,277,Down,0.20394594762262,0.477418922843862
353,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.205660432029069,0.478231724368467
354,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.205727200001473,0.478231724368467
355,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.206387399117699,0.478231724368467
356,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.206896786634431,0.478231724368467
357,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.208222519708077,0.478231724368467
358,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.208355811951796,0.478231724368467
359,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.208355811951796,0.478231724368467
360,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.209321514799736,0.478339799313888
361,WP_MELANOMA,55,Down,0.209951137816689,0.478339799313888
362,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.210592421682135,0.478339799313888
363,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.210724935862793,0.478339799313888
364,WP_CAMKK2_PATHWAY,30,Down,0.212512766842308,0.479205819412859
365,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.212895243717923,0.479205819412859
366,WP_ACUTE_VIRAL_MYOCARDITIS,67,Down,0.213141346742905,0.479205819412859
367,WP_SPINA_BIFIDA,10,Down,0.213432688986067,0.479205819412859
368,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.214064704893349,0.479318795739456
369,WP_TRYPTOPHAN_METABOLISM,19,Up,0.216627962976874,0.483743743883317
370,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.217431882600701,0.484226679089128
371,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.219432442161723,0.48736477720016
372,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.221892807463608,0.491504498252722
373,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.223164746158398,0.492996651030884
374,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.22609300942199,0.498130052844169
375,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.227507401710774,0.499909597359142
376,WP_RETINOL_METABOLISM,6,Down,0.231372874606373,0.507051193286306
377,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.233876823192493,0.511179051221788
378,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.236706647976308,0.513059671394107
379,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.236996032335036,0.513059671394107
380,WP_BDNFTRKB_SIGNALING,26,Down,0.237468847839684,0.513059671394107
381,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.237694968002569,0.513059671394107
382,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.238086653595364,0.513059671394107
383,WP_CILIARY_LANDSCAPE,185,Down,0.238473123961096,0.513059671394107
384,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.240320108084734,0.515686898598493
385,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.242369102923629,0.518732833270312
386,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.244186454134597,0.521268492764011
387,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.245272334784811,0.52170758329608
388,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,43,Down,0.245658425144271,0.52170758329608
389,WP_ARYLAMINE_METABOLISM,1,Up,0.246622845484177,0.522409317940776
390,WP_NRF2ARE_REGULATION,20,Up,0.2477265862689,0.523123126708455
391,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.248229541921124,0.523123126708455
392,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.249677411321115,0.524832109511731
393,WP_MALE_INFERTILITY,70,Up,0.251645720001184,0.527623596134797
394,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.255377327797737,0.534088624632831
395,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.256029986018499,0.534097996149983
396,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.258514228917005,0.536961061083197
397,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.25870575394421,0.536961061083197
398,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.261535270450547,0.540270450291117
399,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.261611540856985,0.540270450291117
400,WP_IRON_METABOLISM_DISORDERS,13,Up,0.263713204891638,0.543249202076773
401,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.265649113641878,0.545872492870094
402,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.268227862990607,0.548433581839345
403,WP_BARDETBIEDL_SYNDROME,65,Up,0.268236855637907,0.548433581839345
404,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Down,0.269555091535872,0.548433581839345
405,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.269557767772979,0.548433581839345
406,WP_IDO_METABOLIC_PATHWAY,8,Up,0.274967609178823,0.558062339811207
407,WP_IL9_SIGNALING,15,Up,0.275936187123786,0.558652133144962
408,WP_FRAGILE_X_SYNDROME,85,Down,0.279118967387394,0.563710855703952
409,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.27996406357901,0.564035179435464
410,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Down,0.282903624588247,0.568567284538331
411,WP_RAS_SIGNALING,119,Down,0.284498230849893,0.570380881314627
412,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.286772058643738,0.57305812861079
413,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.28722452319934,0.57305812861079
414,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.288191290127053,0.573598123344665
415,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.291501357879043,0.578227041361644
416,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.292011234849644,0.578227041361644
417,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.293595639363398,0.578227041361644
418,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.294408715228092,0.578227041361644
419,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.294862080328016,0.578227041361644
420,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.295511097842028,0.578227041361644
421,WP_ASPIRIN_AND_MIRNAS,8,Down,0.296460890972162,0.578227041361644
422,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.296980134191837,0.578227041361644
423,WP_TOLLLIKE_RECEPTOR_SIGNALING,81,Down,0.297335381509918,0.578227041361644
424,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.298091452881053,0.578227041361644
425,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.298236034682887,0.578227041361644
426,WP_BLADDER_CANCER,30,Down,0.300293100070995,0.580848625489436
427,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.301686092435573,0.580955535671523
428,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.302240926002257,0.580955535671523
429,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.302463500974616,0.580955535671523
430,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.30572343894421,0.585851427186115
431,WP_SELENIUM_MICRONUTRIENT_NETWORK,52,Down,0.30858137955587,0.588686131457634
432,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,9,Up,0.308631564065168,0.588686131457634
433,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.30972685008488,0.588694521463482
434,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.310064832906737,0.588694521463482
435,WP_CYTOSINE_METHYLATION,7,Down,0.311842612112447,0.590708764093464
436,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.314890428909192,0.595114021608198
437,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.316878483209874,0.596437464443803
438,WP_IL3_SIGNALING,46,Down,0.317038360954352,0.596437464443803
439,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.318092499973049,0.597057448696565
440,WP_PYRIMIDINE_METABOLISM,71,Down,0.321499917505578,0.602081663692264
441,WP_BREAST_CANCER_PATHWAY,88,Down,0.32333007842441,0.604136019550371
442,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.325333406335327,0.604707183101952
443,WP_IL19_SIGNALING,20,Down,0.326603915485557,0.604707183101952
444,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.3268593002181,0.604707183101952
445,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.327218344344602,0.604707183101952
446,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Up,0.327305101533338,0.604707183101952
447,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.328380976579235,0.605337639152773
448,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.331129472678897,0.607750242642986
449,WP_HIPPOYAP_SIGNALING,16,Down,0.331737927659858,0.607750242642986
450,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.331902438336582,0.607750242642986
451,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.333990803537642,0.610218230853696
452,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Down,0.336447513282443,0.613346794125515
453,WP_OSTEOPONTIN_SIGNALING,12,Up,0.339614175954387,0.614989989812813
454,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.340005809907965,0.614989989812813
455,WP_VITAMIN_D_RECEPTOR_PATHWAY,87,Down,0.340086507403135,0.614989989812813
456,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.34043406389427,0.614989989812813
457,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.341080613282106,0.614989989812813
458,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.344022178651506,0.618939465521487
459,WP_ADIPOGENESIS,87,Down,0.348848206698374,0.625124893513755
460,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.34918597116315,0.625124893513755
461,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.349736135812914,0.625124893513755
462,WP_ESTROGEN_SIGNALING,21,Down,0.351505954236115,0.625593148552623
463,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.351691830671442,0.625593148552623
464,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.352641465528304,0.625593148552623
465,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.353034968540012,0.625593148552623
466,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.358588686603526,0.632610757625111
467,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.359059978067932,0.632610757625111
468,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.359298342923,0.632610757625111
469,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.360565591956603,0.633488374780898
470,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.361872637644078,0.634432028550469
471,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.364017841933532,0.636546085315625
472,WP_DNA_MISMATCH_REPAIR,21,Up,0.364623485763319,0.636546085315625
473,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.36676913009136,0.63886928620365
474,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.367504904927828,0.63886928620365
475,WP_PPAR_SIGNALING,39,Up,0.380041661142776,0.657699429399231
476,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Down,0.380356324045823,0.657699429399231
477,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.380731344445914,0.657699429399231
478,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Up,0.38340282552938,0.658404956907296
479,WP_AEROBIC_GLYCOLYSIS,10,Down,0.383536868101337,0.658404956907296
480,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.383536868101337,0.658404956907296
481,WP_IL5_SIGNALING,37,Down,0.392133233254056,0.671762545117135
482,WP_TRANSSULFURATION_PATHWAY,8,Down,0.394235734130342,0.673963163741497
483,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.395892774174452,0.675394712049169
484,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.396979828456605,0.675849955884799
485,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.398193994562195,0.676519281482986
486,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.399480483458216,0.67730847401146
487,WP_CELL_CYCLE,95,Down,0.401161458138232,0.678761892209246
488,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.402712245411022,0.679989529136644
489,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.410068419972669,0.687657170455269
490,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.410690537667552,0.687657170455269
491,WP_MRNA_PROCESSING,124,Down,0.411734354459226,0.687657170455269
492,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.412123308305149,0.687657170455269
493,WP_SLEEP_REGULATION,12,Up,0.412232592527106,0.687657170455269
494,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.412260488112746,0.687657170455269
495,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.41415302925063,0.688819646842603
496,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.414629301982926,0.688819646842603
497,WP_GLUTATHIONE_METABOLISM,10,Down,0.417700488294177,0.69150726511366
498,WP_JOUBERT_SYNDROME,71,Up,0.417925507313838,0.69150726511366
499,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.418788988507237,0.691547347755437
500,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.420045611076474,0.69223516705403
501,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.424467491367309,0.698126173426472
502,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.425398501617586,0.698263675961934
503,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.429227104882687,0.703147384539431
504,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.431020532348237,0.704684362410609
505,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.435757335671026,0.706574059138559
506,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.435809951364837,0.706574059138559
507,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.436308607369847,0.706574059138559
508,WP_ONECARBON_METABOLISM,22,Down,0.437534649944753,0.706574059138559
509,WP_GPR40_PATHWAY,8,Up,0.437619019106622,0.706574059138559
510,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.438419217174523,0.706574059138559
511,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.439232384598393,0.706574059138559
512,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.439757952323089,0.706574059138559
513,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.440714458835377,0.706574059138559
514,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.440751294171382,0.706574059138559
515,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.442621001175593,0.707786333004393
516,WP_PDGFRBETA_PATHWAY,27,Down,0.44322542212411,0.707786333004393
517,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.447414238195033,0.712887654583473
518,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.448150248876503,0.712887654583473
519,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.451285632251697,0.715222248493076
520,WP_AMINO_ACID_METABOLISM,60,Down,0.451871761097366,0.715222248493076
521,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.4528440973758,0.715222248493076
522,WP_LUNG_FIBROSIS,37,Down,0.453089822467701,0.715222248493076
523,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.45427618855876,0.715723861132731
524,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.456693064555025,0.717549309955691
525,WP_CILIOPATHIES,128,Up,0.457176441415944,0.717549309955691
526,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.459084521205908,0.719174230938533
527,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.460040115105514,0.71930370938699
528,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.464322463401307,0.721227200187868
529,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.464458364689772,0.721227200187868
530,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.464541093347021,0.721227200187868
531,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.464771411771551,0.721227200187868
532,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.468199847618484,0.725181718867726
533,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.476649216422055,0.734430517604696
534,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.476787433484236,0.734430517604696
535,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.477268767104403,0.734430517604696
536,WP_CHOLESTASIS,9,Up,0.477736356111793,0.734430517604696
537,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.482485862152048,0.738505403330157
538,WP_STEROID_BIOSYNTHESIS,2,Up,0.482840102089032,0.738505403330157
539,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.484051978448036,0.738505403330157
540,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.485246469606429,0.738505403330157
541,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.48559011389939,0.738505403330157
542,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Down,0.485764476462312,0.738505403330157
543,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Down,0.48937466789123,0.740419173456224
544,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.489662080007392,0.740419173456224
545,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.489718992152478,0.740419173456224
546,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.494140019963702,0.745735121703463
547,WP_ANGIOGENESIS,15,Up,0.49680405010393,0.748384894489284
548,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.500531424548699,0.750786469346536
549,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.500877610302342,0.750786469346536
550,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.501882232624094,0.750786469346536
551,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.502042893944104,0.750786469346536
552,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.503110342338464,0.751019786389302
553,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.506072729772989,0.754075821578559
554,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.50922744689156,0.754341234923575
555,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.510109468068911,0.754341234923575
556,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.510669222500483,0.754341234923575
557,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.510721953407398,0.754341234923575
558,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.511927266392959,0.754341234923575
559,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.512239042182793,0.754341234923575
560,WP_PPARALPHA_PATHWAY,15,Up,0.512659091695634,0.754341234923575
561,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.514825193618605,0.756178181001302
562,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.517300126107667,0.757635691191208
563,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,36,Down,0.518874331643793,0.757635691191208
564,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.519321603038691,0.757635691191208
565,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.521153681352743,0.757635691191208
566,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.521388369757017,0.757635691191208
567,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.521963774781823,0.757635691191208
568,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.523821519584752,0.757635691191208
569,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.524349763673147,0.757635691191208
570,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.525092648037007,0.757635691191208
571,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,140,Down,0.526548336753659,0.757635691191208
572,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.527045869233227,0.757635691191208
573,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.527691465903568,0.757635691191208
574,WP_NEPHROGENESIS,4,Up,0.52777049362106,0.757635691191208
575,WP_RANKLRANK_SIGNALING,47,Down,0.528947716106896,0.758005074907969
576,WP_ENDODERM_DIFFERENTIATION,82,Down,0.529921852156163,0.758082649612289
577,WP_CANCER_PATHWAYS,310,Down,0.531597659394625,0.759161995391977
578,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.536204334989738,0.764415868566685
579,WP_TGFB_SMAD_SIGNALING,7,Down,0.54128500149072,0.768650747081226
580,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.541635288118758,0.768650747081226
581,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.542056658808734,0.768650747081226
582,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.542906231554943,0.768650747081226
583,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.54538594567133,0.77083708273272
584,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.549979119627893,0.775997935913328
585,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.553308341013052,0.778578506388308
586,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.553697821290714,0.778578506388308
587,WP_IL6_SIGNALING,40,Down,0.562026566203975,0.788276728010436
588,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Down,0.564111404521709,0.788276728010436
589,WP_MACROPHAGE_MARKERS,8,Up,0.564532797571298,0.788276728010436
590,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.56492336394895,0.788276728010436
591,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.566268046663899,0.788276728010436
592,WP_MONOAMINE_TRANSPORT,12,Down,0.566334736628857,0.788276728010436
593,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.570630629786904,0.792173007239537
594,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.571056755218792,0.792173007239537
595,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.573702722171966,0.794505954738991
596,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.575703961006354,0.79480604239518
597,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.576813123000386,0.79480604239518
598,WP_HEME_BIOSYNTHESIS,8,Down,0.576813123000386,0.79480604239518
599,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.579972229084986,0.79782490278135
600,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.584758522236292,0.803068370537841
601,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.587611706864656,0.805644004087315
602,WP_NRF2_PATHWAY,72,Up,0.588650841760103,0.805728062475622
603,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.592799098326811,0.808792725725885
604,WP_ID_SIGNALING,12,Down,0.592852920313634,0.808792725725885
605,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.595587434527783,0.811180241406435
606,WP_KALLMANN_SYNDROME,11,Down,0.603174955878493,0.820158685880987
607,WP_ATM_SIGNALING,34,Up,0.607183677687413,0.824249341704165
608,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,41,Down,0.611562178516,0.828827689304579
609,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.616393014039779,0.834003027206532
610,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.618904993842792,0.835682059674594
611,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.619662303957739,0.835682059674594
612,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.622893177788123,0.838666631531721
613,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.629764575506496,0.846535090077248
614,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.633710532471323,0.849055960991348
615,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.634162617896631,0.849055960991348
616,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.635464380107562,0.849055960991348
617,WP_SERINE_METABOLISM,5,Down,0.636932024745766,0.849055960991348
618,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.63732479071558,0.849055960991348
619,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.63782237846316,0.849055960991348
620,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.642257042917161,0.850806252228949
621,WP_TRANSLATION_FACTORS,49,Down,0.642905662014938,0.850806252228949
622,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.642984614011057,0.850806252228949
623,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.643267348469218,0.850806252228949
624,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.644940919931177,0.851296197576767
625,WP_VITAMIN_B12_DISORDERS,9,Down,0.645704033356164,0.851296197576767
626,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.64869774650594,0.852515060798875
627,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.64869774650594,0.852515060798875
628,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.655148391197047,0.859543934364183
629,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.656950213975358,0.859543934364183
630,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.657175580885237,0.859543934364183
631,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.658491271848992,0.859899854205339
632,WP_CCL18_SIGNALING,22,Down,0.660641466352008,0.86051456079639
633,WP_ALLOGRAFT_REJECTION,51,Down,0.66204758431291,0.86051456079639
634,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.662779552390878,0.86051456079639
635,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.663815923581897,0.86051456079639
636,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.666769755632611,0.86051456079639
637,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.668619857747513,0.86051456079639
638,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.668945686071215,0.86051456079639
639,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.669328350704602,0.86051456079639
640,WP_VALPROIC_ACID_PATHWAY,9,Down,0.669404649406447,0.86051456079639
641,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.669405137706901,0.86051456079639
642,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.670975265198746,0.861189436952908
643,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Down,0.67343207194739,0.862998487223405
644,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.682205021484684,0.871586950933668
645,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.682249494359485,0.871586950933668
646,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.68822297320791,0.876237056385951
647,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.688767759438263,0.876237056385951
648,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.689079626866621,0.876237056385951
649,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.692562538392417,0.878634647145992
650,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.694367567597017,0.878634647145992
651,WP_BURN_WOUND_HEALING,63,Down,0.695221271340661,0.878634647145992
652,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.696408359000301,0.878634647145992
653,WP_MTHFR_DEFICIENCY,18,Down,0.696978662355121,0.878634647145992
654,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.69736293596296,0.878634647145992
655,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Up,0.699383503893493,0.879835125508761
656,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.702227493568281,0.882066241921133
657,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.709693779684094,0.889040943840632
658,WP_IL4_SIGNALING,50,Down,0.710503943158642,0.889040943840632
659,WP_NEPHROTIC_SYNDROME,27,Down,0.711016968435651,0.889040943840632
660,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.714218545050935,0.890183149302044
661,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.71443601449385,0.890183149302044
662,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.716290717970961,0.890183149302044
663,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.716411198942309,0.890183149302044
664,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.718449887167695,0.890183149302044
665,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.71936126964062,0.890183149302044
666,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.719492691062089,0.890183149302044
667,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.72063611595678,0.890261108768196
668,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.72557108972564,0.8943463207753
669,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.726129176893732,0.8943463207753
670,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.727199071504188,0.8943463207753
671,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.729470659424125,0.895781249012051
672,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.730540047737984,0.895781249012051
673,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.73770130650076,0.903003325358792
674,WP_IL2_SIGNALING,37,Down,0.738621652053186,0.903003325358792
675,WP_OSTEOCLAST_SIGNALING,9,Up,0.741093880439998,0.904683492566754
676,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.746065848342425,0.909405708630411
677,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.747391071970351,0.90967539631251
678,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.749919250876901,0.911406287201425
679,WP_GLYOXYLATE_METABOLISM,5,Down,0.752725488089764,0.913469517210553
680,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.754820868060125,0.91466528717874
681,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Down,0.757288522558634,0.916307992053326
682,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.758794875027647,0.916317384997803
683,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.759520356739684,0.916317384997803
684,WP_MEASLES_VIRUS_INFECTION,102,Up,0.762834677158247,0.918970429792976
685,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.764845980740806,0.920048303840035
686,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.76793336520347,0.922167781087276
687,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.76892651581467,0.922167781087276
688,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.771685767257918,0.922167781087276
689,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.772353780889973,0.922167781087276
690,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.776000282976966,0.922167781087276
691,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.778374694316566,0.922167781087276
692,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.779369034171243,0.922167781087276
693,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.779492999000109,0.922167781087276
694,WP_ENDOCHONDRAL_OSSIFICATION,28,Down,0.779661116885061,0.922167781087276
695,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Down,0.779661116885061,0.922167781087276
696,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.779973449332764,0.922167781087276
697,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.780407360585278,0.922167781087276
698,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.781895925384438,0.922167781087276
699,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.782275824004862,0.922167781087276
700,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.783773466784523,0.922613338043496
701,WP_VITAMIN_B12_METABOLISM,25,Up,0.787200267188081,0.92413742540545
702,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.787311253197361,0.92413742540545
703,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.788700427751953,0.924451141490198
704,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.791164890390098,0.925099712735437
705,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.792144634310102,0.925099712735437
706,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.793539236369754,0.925099712735437
707,WP_METHYLATION_PATHWAYS,5,Down,0.795919421862148,0.925099712735437
708,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.796260525215199,0.925099712735437
709,WP_KLEEFSTRA_SYNDROME,25,Down,0.797725792505669,0.925099712735437
710,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.798096640060501,0.925099712735437
711,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.798235310382155,0.925099712735437
712,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.801767849346079,0.927135180870431
713,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.802241970825992,0.927135180870431
714,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.806434992275772,0.9297612713842
715,WP_SILDENAFIL_TREATMENT,11,Up,0.806771006116144,0.9297612713842
716,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.808797523997701,0.929790952494555
717,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.809053535119655,0.929790952494555
718,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.813512736605771,0.933276091213845
719,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.814665833505115,0.933276091213845
720,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.815483963196564,0.933276091213845
721,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.817282775828459,0.934037458089668
722,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.822748743382848,0.938981945356603
723,WP_PREIMPLANTATION_EMBRYO,21,Down,0.826298689339027,0.939790603049965
724,WP_APOPTOSIS,72,Down,0.826836604057186,0.939790603049965
725,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.828664060962647,0.939790603049965
726,WP_IL17_SIGNALING,25,Up,0.829368093574131,0.939790603049965
727,WP_AUTOPHAGY,27,Down,0.830028056913673,0.939790603049965
728,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.830300435704338,0.939790603049965
729,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.831478183982032,0.939832679837029
730,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.83550751767359,0.940596958346125
731,WP_FERROPTOSIS,51,Up,0.836450161278973,0.940596958346125
732,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Down,0.836492243000188,0.940596958346125
733,WP_FOXA2_PATHWAY,9,Up,0.836865005975029,0.940596958346125
734,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.837861853672398,0.940596958346125
735,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.839998624680983,0.941168357625664
736,WP_DNA_REPLICATION,36,Up,0.840655232053991,0.941168357625664
737,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.84533880650183,0.94512778366012
738,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Down,0.847450214613163,0.946182154665446
739,WP_FOLATE_METABOLISM,38,Down,0.848578412982724,0.946182154665446
740,WP_NRXN1_DELETION_SYNDROME,2,Up,0.850119863512968,0.946619956127953
741,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.85437940191963,0.949293902942755
742,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.855000343488438,0.949293902942755
743,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.856276887709339,0.949293902942755
744,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.857129446346371,0.949293902942755
745,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.85954695673809,0.950693546781458
746,WP_ALSTROM_SYNDROME,27,Down,0.865649077671273,0.953514974965386
747,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Down,0.86633355293759,0.953514974965386
748,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.866381221719377,0.953514974965386
749,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.867236039899162,0.953514974965386
750,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.86788377575733,0.953514974965386
751,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.869317010730488,0.95381786530216
752,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.87083935267577,0.954217588570259
753,WP_ECTODERM_DIFFERENTIATION,78,Up,0.877147419429941,0.959853218605938
754,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.880963726222158,0.960712393216798
755,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.88103044208372,0.960712393216798
756,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.882717794145229,0.960712393216798
757,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.884565168729966,0.960712393216798
758,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.885152756187692,0.960712393216798
759,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.886165881978121,0.960712393216798
760,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.886800234264712,0.960712393216798
761,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.887259868007261,0.960712393216798
762,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.891880303123768,0.96352321619713
763,WP_DOPAMINE_METABOLISM,7,Down,0.892194434415546,0.96352321619713
764,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.893729465409774,0.963917643321536
765,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Down,0.904064780593662,0.972541420376946
766,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.904085834962064,0.972541420376946
767,WP_BASE_EXCISION_REPAIR,29,Down,0.907915646170201,0.975255529919046
768,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.908976027885713,0.975255529919046
769,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.914253582576529,0.979642330355084
770,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.917091254206609,0.980071485391189
771,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.918760359361291,0.980071485391189
772,WP_GLUCURONIDATION,7,Down,0.918814611937163,0.980071485391189
773,WP_EICOSANOID_SYNTHESIS,14,Down,0.919852918091221,0.980071485391189
774,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.920724071685726,0.980071485391189
775,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.922956857243307,0.980071485391189
776,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.922979942552867,0.980071485391189
777,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.926833652435867,0.980121724693164
778,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.928263098688224,0.980121724693164
779,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Up,0.930449396235645,0.980121724693164
780,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.93095943592005,0.980121724693164
781,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.930998055106675,0.980121724693164
782,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.931063585704605,0.980121724693164
783,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.931353532081004,0.980121724693164
784,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.934507897859107,0.982186872239673
785,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.938598751910298,0.985229772705842
786,WP_FOXP3_IN_COVID19,10,Down,0.949466069023322,0.991043384328258
787,WP_PI3KAKT_SIGNALING,182,Down,0.95012708996116,0.991043384328258
788,WP_KININKALLIKREIN_PATHWAY,2,Down,0.950166401324766,0.991043384328258
789,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.951338955982992,0.991043384328258
790,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.951690189364512,0.991043384328258
791,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.951905936394085,0.991043384328258
792,WP_CELLULAR_PROTEOSTASIS,6,Down,0.952790480129756,0.991043384328258
793,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.953758985160568,0.991043384328258
794,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.95761050143819,0.992072786051711
795,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.957951223612736,0.992072786051711
796,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.958783885713706,0.992072786051711
797,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.960282890749894,0.992072786051711
798,WP_MIRNA_BIOGENESIS,6,Up,0.960769518530662,0.992072786051711
799,WP_IL7_SIGNALING,23,Down,0.964709099801014,0.993137444845011
800,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.965239749482976,0.993137444845011
801,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.966016335447474,0.993137444845011
802,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.967672211997222,0.993137444845011
803,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.968502897018354,0.993137444845011
804,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.969032167057511,0.993137444845011
805,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,36,Down,0.977512169553536,0.99549630596654
806,WP_NUCLEOTIDE_GPCRS,7,Down,0.97890170911745,0.99549630596654
807,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.979123405881729,0.99549630596654
808,WP_TP53_NETWORK,16,Down,0.980201057563846,0.99549630596654
809,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.980435757393682,0.99549630596654
810,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.98112774567492,0.99549630596654
811,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.981454132731571,0.99549630596654
812,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.98214840238469,0.99549630596654
813,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.982731674159965,0.99549630596654
814,WP_IL11_SIGNALING,40,Down,0.984716429432734,0.99549630596654
815,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.985332117281647,0.99549630596654
816,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.986632000538862,0.99549630596654
817,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.987087059870217,0.99549630596654
818,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.989107780034114,0.99549630596654
819,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.989455673041986,0.99549630596654
820,WP_DNA_DAMAGE_RESPONSE,59,Down,0.992411533871269,0.99612326519705
821,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.992577099895291,0.99612326519705
822,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.993794524906979,0.99612326519705
823,WP_IL18_SIGNALING,193,Up,0.994914377739286,0.99612326519705
824,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.997276742171152,0.997276742171152
